CME Group (CME) Stock Looks Fully Priced After A 74% Run

CME Group has delivered strong share-price gains in recent years, which puts a spotlight on whether the current valuation is supported by the returns the business earns on its capital. With the stock recently closing at US$308.06, the key issue for you is how well that price lines up with the cash the company can generate from every dollar it invests back into the business.

• Over the past 5 years, CME Group has returned 74.1%, which puts real weight on the question of whether those gains are backed by durable returns on its capital base.
• Recent records in trading activity, including very high cryptocurrency derivatives volumes and expansion into new contracts like baseball and future tungsten and dairy products, can influence expectations for how efficiently CME turns its trading franchise and clearing infrastructure into sustained returns on invested funds.
• What if you looked at CME Group through its earnings instead? See what CME Group's 25.0x P/E says about the price.

The stock's next move may depend on whether the returns CME Group earns on its capital are strong enough to justify where the shares trade today.

If you are considering CME Group's recent 18.0% one year return and record trading volumes, it can be helpful to compare this capital efficiency theme with a broader group of 29 high quality undervalued stocks.

Does CME Group Look Pricey on Excess Returns?

The Excess Returns model looks at how much value CME Group creates above the cost of equity for each dollar of shareholder capital. It focuses less on headline growth and more on the spread between profitability and required return.

On this view, CME Group is modeled with book value of $74.31 per share and a stable book value estimate of $81.20 per share, while stable EPS is set at $13.76 per share based on analyst expectations for future return on equity. The framework assumes an average return on equity of 16.94% against a cost of equity of $6.44 per share, leaving an excess return of $7.32 per share that the model treats as value created over time rather than a one off outcome.

Record Q3 2026 revenue and strong crypto derivatives activity help explain why the market is willing to pay $308.06 per share despite the Excess Returns projections putting the estimated intrinsic value meaningfully below the current share price. Find out what CME Group could be worth using our Excess Returns estimate.

The CME Group Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the valuation puzzle for CME Group leaves off. They spell out the specific assumptions on growth, margins and earnings that would need to hold for the stock to be worth significantly more or less than today’s price, and each one treats fair value as a clear thesis about CME Group's business that you can revisit over time, rather than a single static snapshot.

A written, number driven Narrative on CME Group gives you a clear yardstick for whether record revenue, high crypto derivatives volumes and new contracts in areas like tungsten and European dairy products translate into returns that match today’s share price. It also creates a simple way to track how your view on CME Group’s growth, margins and execution holds up as fresh trading data, product launches and regulatory outcomes arrive.

Share your own Narrative for CME Group and set out the assumptions behind your valuation.

CME Group’s price tag is one thing, who is steering the ship is another

Before you focus only on what CME Group might be worth, it pays to ask who allocates the capital, sets the risk appetite and gets rewarded for those choices. See who runs CME Group and how they are paid.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com